Stay up to date with the latest news and announcements from NASCSA.
A new report issued on April 7, 2022 by the Veterans Administration Inspector General's Office has found that the Veteran's Administration failed to consistently notify state medical boards when department physicians are fired for malpractice or incompetence, a situation that could put...
The U.S. Food and Drug Administration and the U.S. Drug Enforcement Administration recently issued joint warning letters to operators of two websites illegally selling Schedule II stimulants, including amphetamine drug products marketed as Adderall. These websites sell Adderall online without a...
On April 11, 2022, the Drug Enforcement Administration (DEA) will publish a Final Rule in the Federal Register to amend its regulations to require all new and renewal applications for DEA registration to be submitted only through a secure online portal. The Rule becomes effective 30 days after...
A Missouri task force assigned with overseeing the creation of a statewide prescription drug monitoring program has hired a former state health department veteran to serve as the program?s executive director.
Dean Linneman, the former director of the Department of Health and Senior...
WASHINGTON, DC ? Today, the Drug Enforcement Administration issued a Public Safety Alert warning Americans of the alarming increase in the lethality and availability of fake prescription pills containing fentanyl and methamphetamine. DEA?s Public Safety Alert, the first in six...
In March of 2022 NASCSA conducted a survey of it?s state members requesting their input on a recent petition submitted Public Citizen to the FDA and DEA to place gabapentin and gabapentin enacarbil on schedule V of the Controlled Substances Act. Attached please find the results of the survey...
Senate Bill 132 passed the Senate by a vote of 16-0 and is now on its way to the Alaska House of Representatives for consideration. For more information, please contact the Senate Majority Press office at (907) 465-4066.
Prescription Drug Monitoring Programs are designed for use in human...
Another study that finds increase in drug overdoses after state implements PDMP reporting.
Note: It's important to read and understand the studies. Authors providing news/summaries may inject personal bias or have other motives. Like with everything you...
On Monday, March 14, 2022, President Biden signed into law S. 854, the Methamphetamine Response Act of 2021, which designates methamphetamine as an emerging drug threat and requires the Office of National Drug...
RxGov by Tyler Technologies
RxGov is a leading Prescription Monitoring Platform (PMP) that improves access to clinical data pertinent to a patient's medication history and the risk factors associated with substance use disorder through the capture, analysis, proactive monitoring, and open sharing of a state's prescription dispense details.
The system is one of the most interoperable, integrated and intuitive on the market. It also includes complete oversight and compliance with the state's current PDMP system, including statewide mandates. RxGov allows the PDMP administrator unprecedented access to insightful data sets, such as query history and compliance reports at all levels: state, region, organization, and individual prescriber. Freely accessible data, enhanced by useful visualization tools, is central to RxGov.
To learn more about RxGov and how the platform can help state governments fight the opioid crisis, email email@example.com or download our one pager.